Evidence map›Paper›PMID 32975150›Full record

ArticleClinical EEG and neuroscience2021

Special Report on the Impact of the COVID-19 Pandemic on Clinical EEG and Research and Consensus Recommendations for the Safe Use of EEG.

Salvatore Campanella, Kemal Arikan, Claudio Babiloni, Michela Balconi, Maurizio Bertollo, Viviana Betti, Luigi Bianchi, Martin Brunovsky, Carla Buttinelli, Silvia Comani and 26 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical EEG and neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The Early Impacts of the COVID-19 Pandemic on Mental Health Facilities and Psychiatric Professionals.International journal of environmental research and public health · 2021
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Salvatore CampanellaLaboratoire de Psychologie Médicale et d'Addictologie, ULB Neuroscience Institute (UNI), CHU Brugmann-Université Libre de Bruxelles (U.L.B.), Belgium.
Kemal ArikanKemal Arıkan Psychiatry Clinic, Istanbul, Turkey.
Claudio BabiloniDepartment of Physiology and Pharmacology "Erspamer", Sapienza University of Rome, Italy.
Michela BalconiResearch Unit in Affective and Social Neuroscience, Department of Psychology, Catholic University of Milan, Milan, Italy.
Maurizio BertolloBIND-Behavioral Imaging and Neural Dynamics Center, Department of Neuroscience, Imaging and Clinical Sciences, University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.
Viviana BettiDepartment of Psychology, Sapienza University of Rome, Fondazione Santa Lucia, Rome, Italy.
Luigi BianchiDipartimento di Ingegneria Civile e Ingegneria Informatica (DICII), University of Rome Tor Vergata, Rome, Italy.
Martin BrunovskyNational Institute of Mental Health, Klecany Czech Republic.
Carla ButtinelliDepartment of Neurosciences, Public Health and Sense Organs (NESMOS), Sapienza University of Rome, Rome, Italy.
Silvia ComaniBIND-Behavioral Imaging and Neural Dynamics Center, Department of Neuroscience, Imaging and Clinical Sciences, University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.
Giorgio Di LorenzoLaboratory of Psychophysiology and Cognitive Neuroscience, Chair of Psychiatry, Department of Systems Medicine, School of Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
Daniel DumalinAZ Sint-Jan Brugge-Oostende AV, Campus Henri Serruys, Lab of Neurophysiology, Department Neurology-Psychiatry, Ostend, Belgium.
Carles EsceraBrainlab-Cognitive Neuroscience Research Group, Department of Clinical Psychology and Psychobiology, Institute of Neurosciences, University of Barcelona, Barcelona, Spain.
Andreas FallgatterDepartment of Psychiatry, University of Tübingen, Germany; LEAD Graduate School and Training Center, Tübingen, Germany.
Derek FisherDepartment of Psychology, Mount Saint Vincent University, and Department of Psychiatry, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.
Giulia Maria GiordanoDepartment of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.
Bahar GuntekinDepartment of Biophysics, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
Claudio ImperatoriCognitive and Clinical Psychology Laboratory, Department of Human Science, European University of Rome, Rome, Italy.
Ryouhei IshiiDepartment of Psychiatry Osaka University Graduate School of Medicine, Osaka, Japan.
Hendrik KajoschLaboratoire de Psychologie Médicale et d'Addictologie, ULB Neuroscience Institute (UNI), CHU Brugmann-Université Libre de Bruxelles (U.L.B.), Belgium.
Michael KiangDepartment of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
Eduardo López-CanedaPsychological Neuroscience Laboratory, Center for Research in Psychology, School of Psychology, University of Minho, Braga, Portugal.
Pascal MissonnierMental Health Network Fribourg (RFSM), Sector of Psychiatry and Psychotherapy for Adults, Marsens, Switzerland.
Armida MucciDepartment of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.
Sebastian OlbrichPsychotherapy and Psychosomatics, Department for Psychiatry, University Hospital Zurich, Zurich, Switzerland.
Georges OtteGroup "Neurotope", Ghent, Belgium.
Andrea PerrottelliDepartment of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.
Alessandra PizzutiDepartment of Psychology, Sapienza University of Rome, Fondazione Santa Lucia, Rome, Italy.
Diego PinalPsychological Neuroscience Laboratory, Center for Research in Psychology, School of Psychology, University of Minho, Braga, Portugal.
Dean SalisburyClinical Neurophysiology Research Laboratory, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Yingying TangShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Paolo TiseiDepartment of Neurosciences, Public Health and Sense Organs (NESMOS), Sapienza University of Rome, Rome, Italy.
Jijun WangShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Istvan WinklerInstitute of Cognitive Neuroscience and Psychology, Research Centre for Natural Sciences, Budapest, Hungary.
Jiajin YuanInstitute of Brain and Psychological Sciences, Sichuan Normal University, Chengdu, China.
Oliver PogarellDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

Funding

Understanding the synaptic, cellular and circuit events of MEG & EEG using a vertically translational cross-species approachRF1MH114223 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOIRON, BRENT D., SALISBURY, DEAN F · 2017 to 2018
$4.0M
Auditory Cortex Connectivity in Emerging PsychosisR01MH113533 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SALISBURY, DEAN F · 2017 to 2021
$3.4M
Auditory Attention in First Episode PsychosisR01MH108568 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SALISBURY, DEAN F · 2016 to 2021
$3.1M
NIMH NIH HHS R01 MH108568NIMH NIH HHS R01 MH113533NIMH NIH HHS RF1 MH114223
6 · The paper itself

Abstract

introductionThe global COVID-19 pandemic has affected the economy, daily life, and mental/physical health. The latter includes the use of electroencephalography (EEG) in clinical practice and research. We report a survey of the impact of COVID-19 on the use of clinical EEG in practice and research in several countries, and the recommendations of an international panel of experts for the safe application of EEG during and after this pandemic.

methodsFifteen clinicians from 8 different countries and 25 researchers from 13 different countries reported the impact of COVID-19 on their EEG activities, the procedures implemented in response to the COVID-19 pandemic, and precautions planned or already implemented during the reopening of EEG activities.

resultsOf the 15 clinical centers responding, 11 reported a total stoppage of all EEG activities, while 4 reduced the number of tests per day. In research settings, all 25 laboratories reported a complete stoppage of activity, with 7 laboratories reopening to some extent since initial closure. In both settings, recommended precautions for restarting or continuing EEG recording included strict hygienic rules, social distance, and assessment for infection symptoms among staff and patients/participants.

conclusionsThe COVID-19 pandemic interfered with the use of EEG recordings in clinical practice and even more in clinical research. We suggest updated best practices to allow safe EEG recordings in both research and clinical settings. The continued use of EEG is important in those with psychiatric diseases, particularly in times of social alarm such as the COVID-19 pandemic.

Indexed as

ConsensusElectroencephalographyBrainBrain MappingCOVID-19HumansMental DisordersSARS-CoV-2COVID-19event-related oscillations (EROs)event-related potentials (ERPs)psychiatryquantitative EEG (qEEG)resting state electroencephalography (rsEEG)

Identifiers

PMID32975150
PMCPMC8121213

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.